FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and Up ...Middle East

News by : (Medscape) -
FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and Up )

Also on site :

Most Viewed News
جديد الاخبار